Efficacy and safety of immunotherapy combined with single-agent chemotherapy as second- or later-line therapy for metastatic non-small cell lung cancerDongna Chen, Yutao Liu, Mingzhao Wang et al.|Frontiers in Immunology|2023Cited by 1